Insilico Medicine has signed a drug discovery collaboration with Eli [...]

Insilico Medicine has nominated ISM6166 as a preclinical candidate, positioning [...]

Insilico Medicine and China Medical System Holdings Limited (CMS) have [...]

A panel of international leaders in neuroscience, artificial intelligence and [...]

Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]